Your browser doesn't support javascript.
loading
Immune-related hematologic adverse events in the context of immune checkpoint inhibitor therapy.
Saliba, Antoine N; Xie, Zhuoer; Higgins, Alexandra S; Andrade-Gonzalez, Xavier A; Fuentes-Bayne, Harry E; Hampel, Paul J; Kankeu Fonkoua, Lionel A; Childs, Daniel S; Rakshit, Sagar; Bezerra, Evandro D; Kommalapati, Anuhya; Lou, Yanyan; Rivera, Candido E; Price, Katharine A; Chintakuntlawar, Ashish; Yan, Yiyi; Schwecke, Anna J; Block, Matthew S; Thanarajasingam, Uma; Thanarajasingam, Gita; Wolanskyj-Spinner, Alexandra P; Marshall, Ariela L; Kottschade, Lisa A; Go, Ronald S; Al-Kali, Aref.
Afiliação
  • Saliba AN; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Xie Z; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Higgins AS; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Andrade-Gonzalez XA; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Fuentes-Bayne HE; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Hampel PJ; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kankeu Fonkoua LA; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Childs DS; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Rakshit S; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Bezerra ED; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kommalapati A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Lou Y; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Rivera CE; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Price KA; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Chintakuntlawar A; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Yan Y; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Schwecke AJ; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Block MS; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Thanarajasingam U; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Thanarajasingam G; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Wolanskyj-Spinner AP; Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.
  • Marshall AL; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
  • Kottschade LA; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USA.
  • Go RS; Division of Hematology and Oncology, Mayo Clinic, Jacksonville, Florida, USA.
  • Al-Kali A; Division of Medical Oncology, Department of Oncology, Mayo Clinic, Rochester, Minnesota, USA.
Am J Hematol ; 96(10): E362-E367, 2021 10 01.
Article em En | MEDLINE | ID: mdl-34137072
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Doenças Hematológicas Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Inibidores de Checkpoint Imunológico / Doenças Hematológicas Limite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Am J Hematol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Estados Unidos